TB Research

Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents

Sampiron EG, Costacurta GF, Baldin VP, Almeida AL, Ieque AL, Santos NC, Alves-Olher VG, Vandresen F, et al. (13 authors)

Future microbiology · 2019-07

Abstract

Aim: To evaluate the potential of three benzohydrazones ( 1 - 3 ), four acylhydrazones derived from isoniazid (INH-acylhydrazones) ( 4 - 7 ) and one hydrazone ( 8 ) as antituberculosis agents. Materials & methods: Inhibitory and bactericidal activities were determined for the reference Mycobacterium tuberculosis ( Mtb ) strain and clinical isolates. Cytotoxicity, drug combinations and ethidium bromide accumulation assays were also performed. Results: The tested compounds ( 1 - 8 ) presented excellent antituberculosis activity with surprisingly inhibitory (0.12-250 μg/ml) and bactericidal values, even against multidrug-resistant Mtb clinical isolates. Compounds showed high selectivity index, with values reaching 1833.33, and a limited spectrum of activity. Some of the compounds ( 2 & 8 ) are also great inhibitors of bacillus efflux pumps. Conclusion: Benzohydrazones and INH-acylhydrazones may be considered scaffolds for the development of new anti- Mtb drugs.

MeSH terms

  • Cell Line, Tumor
  • Hela Cells
  • Vero Cells
  • Animals
  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis
  • Hydrazones
  • Isoniazid
  • Ethidium
  • Antitubercular Agents
  • Microbial Sensitivity Tests
  • Drug Resistance, Multiple, Bacterial
  • Molecular Structure
  • Chlorocebus aethiops